(S (NP (JJ Big) (JJ longitudinal) (JJ observational) (NNS databases)) (VP (VBP present) (NP (DT the) (NN opportunity) (S (VP (TO to) (VP (VB extract) (NP (JJ new) (NN knowledge)) (PP (IN in) (NP (DT a) (ADJP (NN cost) (JJ effective)) (NN manner)))))))) (. .))
(S (ADVP (RB Unfortunately)) (, ,) (NP (NP (DT the) (NN ability)) (PP (IN of) (NP (DT these) (NNS databases))) (S (VP (TO to) (VP (VB be) (VP (VBN used) (PP (IN for) (NP (JJ causal) (NN inference)))))))) (VP (VBZ is) (VP (VBN limited) (PP (JJ due) (TO to) (NP (NP (NP (DT the) (JJ passive) (NN way)) (SBAR (WHPP (IN in) (WHNP (WDT which))) (S (NP (DT the) (NNS data)) (VP (VBP are) (VP (VBN collected)))))) (VP (VBG resulting) (PP (IN in) (NP (NP (JJ various) (NNS forms)) (PP (IN of) (NP (NN bias)))))))))) (. .))
(S (PP (IN In) (NP (DT this) (NN paper))) (NP (PRP we)) (VP (VBP investigate) (NP (NP (DT a) (NN method)) (SBAR (WHNP (WDT that)) (S (VP (MD can) (VP (VP (VB overcome) (NP (DT these) (NNS limitations))) (CC and) (VP (NN determine) (NP (NN causal) (NN contrast) (NN set) (NNS rules)) (ADVP (RB efficiently)) (PP (IN from) (NP (JJ big) (NNS data)))))))))) (. .))
(S (PP (IN In) (NP (JJ particular))) (, ,) (NP (PRP we)) (VP (VBP present) (NP (DT a) (JJ new) (NN methodology)) (PP (IN for) (NP (NP (DT the) (NN purpose)) (PP (IN of) (S (VP (VBG identifying) (NP (NP (NN risk) (NNS factors)) (SBAR (WHNP (WDT that)) (S (VP (VBP increase) (NP (NP (DT a) (NNS patients) (NN likelihood)) (PP (IN of) (S (VP (VBG experiencing) (NP (NP (DT the) (VBN known) (JJ rare) (NN side) (NN effect)) (PP (IN of) (NP (JJ renal) (NN failure)))) (PP (IN after) (S (VP (VBG ingesting) (NP (NNS aminosalicylates))))))))))))))))))) (. .))
(S (NP (DT The) (NNS results)) (VP (VP (VBP show) (SBAR (IN that) (S (NP (DT the) (NN methodology)) (VP (VBD was) (ADJP (JJ able) (S (VP (TO to) (VP (VB identify) (NP (NP (ADJP (RB previously) (VBN researched)) (NN risk) (NNS factors)) (PP (JJ such) (IN as) (S (VP (VBG being) (VP (VBN prescribed) (NP (NNS diuretics))))))))))))))) (CC and) (VP (VBD highlighted) (SBAR (IN that) (S (NP (NP (NNS patients)) (PP (IN with) (NP (NP (DT a) (ADJP (JJR higher) (IN than) (JJ average)) (NN risk)) (PP (IN of) (NP (JJ renal) (NN failure)))))) (VP (MD may) (VP (VB be) (ADJP (ADVP (RB even) (RBR more)) (JJ susceptible) (PP (TO to) (S (VP (VBG experiencing) (NP (PRP it)) (PP (IN as) (NP (DT a) (NN side) (NN effect))) (PP (IN after) (S (VP (VBG ingesting) (NP (NNS aminosalicylates))))))))))))))) (. .))
